Pricing Log in Create free account
Friday 6 November 2026 Export TRLV’s income statement to Excel — free account

Trulieve Cannabis Corp.

TRLV Healthcare Drug Manufacturers Specialty & Generic

Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.

Revenue
−20.1%
EPS
−2,391.1%
Free cash flow
+24.5%
Total debt
−37.0%

Quarter to September 2026, against a year earlier

11.10 0.20 +1.83%
Market cap
$2.1B
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
6/9
Altman Z
0.98
Beneish M
−2.99
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Trulieve Cannabis Corp. (TRLV) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Trulieve Cannabis Corp. (TRLV) trades at a EV/Sales of 2.0×. Over the past ten years it has ranged from 0.0× (December 2021) to 4.3× (January 2022); the current reading is higher than 77% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.9× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.4× 38.90%
FY2024 1.0× (10.60%)
FY2023 1.2× (24.17%)
FY2022 1.5× (63.75%)
FY2021 4.2× —
FY2020 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.0× 16.85%
Jun 2026 1.7× 81.14%
Mar 2026 0.9× (35.50%)
Dec 2025 1.4× 4.89%
19 more quarters

Against its own ten years

Low 0.0× High 4.3×
Ten-year median 1.3×
Current reading's percentile 73

EV/Sales against peers

Company EV/Sales
HCM HUTCHMED (China) Limited Sponsored ADR compare −0.1×
RGC Regencell Bioscience Holdings Limited compare n/m
PRGO Perrigo Company plc compare 1.2×
ANIP ANI Pharmaceuticals, Inc. compare 1.6×
TRLV Trulieve Cannabis Corp. 2.0×
BCRX BioCryst Pharmaceuticals, Inc. compare 2.5×
PBH Prestige Consumer Healthcare Inc. compare 3.5×
XERS Xeris Biopharma Holdings, Inc. compare 6.7×
ALVO Alvotech compare 8.6×
Drug Manufacturers Specialty & Generic industry median 2.9×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TRLV